REDUCE LAP-HF TRIAL

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

July 31, 2018

Conditions
Heart Failure
Interventions
DEVICE

IASD

IASD device implantation

Trial Locations (26)

Unknown

The Prince Charles Hospital, Brisbane

David Kaye, Melbourne

St. Vincent Hospital, Sydney

Medizinische Universität Graz, Graz

Allgemeines Krankenhaus Univesitäts Kliniken, Vienna

OLVZ Aalst, Aalst

Homolka Hospital, Prague

Rigshospitalet, Copenhagen

CHRU de Lille, Lille

CHU de Nantes, Nantes

Hôpital Bichat, Paris

Hôpital La Pitié Salpétrière, Paris

Hôpital Rangueil, Toulouse

Universitatklinikum Duseldorf, Düsseldorf

Georg-August-Universitat, Göttingen

Asklepios Klinik St George, Hamburg

Cardiologicum CRC, Hamburg

University of Heidelberg, Heidelberg

Universtitaät Kliniku Schlewig Holstein, Kiel

Klinikum der Universität Munchen, Munich

St Antonius Ziekenhuis, Nieuwegein

Auckland City Hospital, Auckland

Fourth Military Hospital, Wroclaw

Golden Jubilee Hospital, Glasgow

Royal Brompton/Harefield Trust, Harefield

King's College, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Corvia Medical

INDUSTRY

NCT01913613 - REDUCE LAP-HF TRIAL | Biotech Hunter | Biotech Hunter